Tristel PLC 2016 AR2
The report outlines Tristel plc's financial and operational performance for the fiscal year ended June 30, 2016. The company achieved a 12% increase in revenue to #17.1m and a 27% increase in adjusted pre-tax profit to #3.3m, driven by strong overseas sales growth of 22%. Key strategic milestones included securing 25 overseas regulatory approvals across seven countries and progressing plans to enter the North American infection prevention market. Additionally, Tristel acquired its Australian distributor shortly after the year-end to enhance regional sales and margins.
Company: Tristel PLC
Sector: Health Care
Country: United Kingdom
Year: 2016
Type: AR2
Pages: 44
Tristel PLC
Annual Report And Accounts
The report outlines Tristel plc's financial and operational performance for the fiscal year ended June 30, 2016. The company achieved a 12% increase in revenue to #17.1m and a 27% increase in adjusted pre-tax profit to #3.3m, driven by strong overseas sales growth of 22%. Key strategic milestones included securing 25 overseas regulatory approvals across seven countries and progressing plans to enter the North American infection prevention market. Additionally, Tristel acquired its Australian distributor shortly after the year-end to enhance regional sales and margins.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jul 1, 2015 - Jun 30, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees